ArticleJournal of studies on alcohol and drugs2013
Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
Article in Journal of studies on alcohol and drugs, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- Racial and Ethnic Differences in Long-Term Outcomes among Individuals with Opioid Use Disorder at Opioid Treatment Programs.Journal of racial and ethnic health disparities · 2026Trial
- Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections.Journal of substance abuse treatment · 2015Trial
- The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.Journal of studies on alcohol and drugs · 2014Trial
- A scoping review of interventions addressing social determinants of health and their influence on opioid use disorder outcomes.Drug and alcohol dependence · 2025Article
- Attitudes and Subjective Norms Regarding Medication for Opioid Use Disorder Among Individuals in Treatment for Opioid Use Disorder in the Greater St. Louis Area.Journal of drug issues · 2025Article
- Racial and sex disparities in inpatient outcomes of patients with opioid overdose: a nationwide analysis.Proceedings (Baylor University. Medical Center) · 2025Article
- Prevalence and predictors of medication for opioid use disorder among reproductive-aged women.Drug and alcohol dependence reports · 2024Article
- Demographic differences in the cascade of care for unhealthy alcohol use: A cross-sectional analysis of data from the 2015-2019 National Survey on Drug Use and Health.Alcohol, clinical & experimental research · 2023Article
- Computational analyses identify addiction help-seeking behaviors on the social networking website Reddit: Insights into online social interactions and addiction support communities.PLOS digital health · 2022Article
- Stepped implementation-to-target: a study protocol of an adaptive trial to expand access to addiction medications.Implementation science : IS · 2022Article
- Health Data Disparities in Opioid-Involved Overdose Deaths From 1999 to 2018 in the United States.American journal of public health · 2021Article
- Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.Addiction science & clinical practice · 2021Review
- Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.Psychiatric services (Washington, D.C.) · 2021Article
- It's not just the money: The role of treatment ideology in publicly funded substance use disorder treatment.Journal of substance abuse treatment · 2021Article
- Representative Bureaucracy Through Staff With Lived Experience: Peer Coproduction in the Field of Substance Use Disorder Treatment.American review of public administration · 2020Article
- Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.Journal of substance abuse treatment · 2020Article
- Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.The American journal of drug and alcohol abuse · 2020Article
- Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020Review
- The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.Journal of substance abuse treatment · 2020Article
- A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings.Journal of substance abuse treatment · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivePrior research suggests that publicly funded substance use disorder (SUD) treatment programs lag behind privately funded programs in adoption of evidence-based practices, resulting in disparities in access to high-quality SUD treatment. These disparities highlight a critical public health concern because the majority of SUD patients in the United States are treated in the publicly funded treatment sector. This study uses recent data to examine disparities in access to physicians and availability of medications for the treatment of SUDs between publicly and privately funded SUD treatment programs.
methodData were collected from 595 specialty SUD treatment programs from 2007 to 2010 via face-to-face interviews, mailed surveys, and telephone interviews with treatment program administrators.
resultsPublicly funded programs were less likely than privately funded programs to have a physician on staff, even after controlling for several organizational characteristics that were associated with access to physicians. The results of negative binomial regression indicated that, even after taking into account physician access and other organizational variables, publicly funded programs prescribed fewer SUD medications than privately funded SUD treatment programs.
conclusionsPatients seeking treatment in publicly funded treatment programs continue to face disparities in access to high-quality SUD treatment that supports patients' choices among a range of medication options. However, implementation of the Affordable Care Act may facilitate greater access to physicians and use of medications in publicly funded SUD treatment programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.